|
||
© The Rockefeller University Press,
0021-9525/2000//1019 $5.00
The Journal of Cell Biology, Volume 149, Number 5,
, 2000 1019-1026
Brief Report |
Leydig Cell Loss and Spermatogenic Arrest in Platelet-Derived Growth Factor (Pdgf)-a–Deficient Mice
l.gnessi{at}caspur.it
Platelet-derived growth factor (PDGF)- A–deficient male mice were found to develop progressive reduction of testicular size, Leydig cells loss, and spermatogenic arrest. In normal mice, the PDGF-A and PDGF-R
expression pattern showed positive cells in the seminiferous epithelium and in interstitial mesenchymal cells, respectively. The testicular defects seen in PDGF-A–/– mice, combined with the normal developmental expression of PDGF-A and PDGF-R
, indicate that through an epithelial-mesenchymal signaling, the PDGF-A gene is essential for the development of the Leydig cell lineage. These findings suggest that PDGF-A may play a role in the cascade of genes involved in male gonad differentiation. The Leydig cell loss and the spermatogenic impairment in the mutant mice are reminiscent of cases of testicular failure in man.
Key Words: PDGF-A gene targeting Leydig cell spermatogenesis testis
© 2000 The Rockefeller University Press
| Introduction |
|---|
|
|
|---|
PDGF-A, a high-affinity ligand for the receptor tyrosine kinase PDGF-R
, is required for embryonic and postnatal development (Betsholtz and Raines 1997). PDGF-A–deficient animals develop lung emphysema secondary to the failure of alveolar septation (Boström et al. 1996), defective oligodendrogenesis (Calver et al. 1998; Fruttiger et al. 1999), and skin and hair defects (Karlsson et al. 1999). Previous studies have revealed that PDGF-A may play a role in testicular development (Gnessi et al. 1995) and that Leydig cells express PDGF-R
(Gnessi et al. 1992; Loveland et al. 1995). Here we report the testicular phenotype of PDGF-A–deficient mouse generated by targeted gene disruption. From this study, we conclude that PDGF-A is an essential factor for adult Leydig cells development.
| Materials and Methods |
|---|
|
|
|---|
promoter were generated as previously described (Reinertsen et al. 1997).
In Situ Hybridization
Nonradioactive in situ hybridization using PDGF-A and PDGF-R
probes was performed as described (Boström et al. 1996).
Histology, Immunohistochemistry, and lacZ Staining
Testes to be stained by periodic acid-Schiff (PAS)/haematoxylin, bromodeoxyuridine (BrdU), TdT-mediated dUTP biotin nick end labeling (TUNEL), PDGF-A, PDGF-R
, relaxin-like actor (RLF), and GATA-1 immunohistochemistry were fixed in 4% buffered paraformaldehyde and paraffin embedded. The reactions were carried out on 5-µm sections. For routine histology, sections were stained by PAS/haematoxylin according to standard protocols. For BrdU labeling, BrdU (Sigma-Aldrich) was injected intraperitoneally (100 mg/g body mass). Injected animals were killed 2 h later and the fixed testes were processed as described (Karlsson et al. 1999). Apoptotic cells were detected by TUNEL using the ApopTag Plus in situ detection kit (Oncor) according to the instructions of the manufacturer. Sertoli cells were detected using a GATA-1–specific antibody (Santa Cruz Biotechnology); Leydig cells were detected using a rat anti-RLF antibody (generously provided by Professor Richard Ivell, Institute of Hormone and Fertility Research, Hamburg, Germany); PDGF-A and PDGF-R
–positive cells were detected using rabbit anti-PDGF-A (RDI Inc.) and rat anti-PDGF-R
(PharMingen) antibodies. The antibodies (anti-GATA1, anti-PDGF-A, and anti-PDGF-R
at 1:100 dilution; anti-RLF at 1:1,000 dilution) were incubated overnight at 4°C. The avidin-biotin immunoperoxidase system with 3-amino-9-ethylcarbazole as chromogen was used to visualize bound antibodies (Histostain-Plus kit; Zymed Laboratories). For lacZ staining, transgenic animals were fixed and stained with X-gal for lacZ activity, and 10-µm cryostat testicular sections were treated as described (Reinertsen et al. 1997).
Hormone Assays
Serum testosterone and luteinizing hormone (LH) levels were determined by radioimmunoassays using DiaSorin and Amersham assay systems according to the manufacturers' instructions.
| Results and Discussion |
|---|
|
|
|---|
|
|
|
in embryonic-day-17.5 (E17.5)-P30 WT testis showed the mRNAs expression in seminiferous epithelium and interstitial mesenchymal cells, respectively (Fig. 4, A–H). At E17.5 the PDGF-A and PDGF-R
labeling was rather homogeneous. Later, some PDGF-A–positive tubules and distinct populations of PDGF-R
–positive interstitial cells could be seen. PDGF-R
expression was moreover localized using transgenic mice carrying the reporter gene β-galactosidase (lacZ) under control of the murine PDGF-R
promoter. According to the in situ data, lacZ staining was found in the interstitium (Fig. 4I and Fig. J). The immunohistochemistry for PDGF-A confirmed the intratubular expression of the growth factor which, in agreement with previous results (Gnessi et al. 1992, Gnessi et al. 1995; Loveland et al. 1995), was mainly localized in the cytoplasm of the Sertoli cells (Fig. 5). At P18, although with different intensities, all the tubules were stained (Fig. 5 A). At P42, in line with the in situ findings, only the Sertoli cells in some tubules, corresponding to spermatogenic stages IX-X (Russell et al. 1990), were positive (Fig. 5 B). Altogether, these results indicate that the PDGF-A expression in Sertoli cells depends on the stage of maturation of the associated germ cells. At P42, a weak signal was also found in some interstitial cells (Fig. 5 B), which is consistent with the reported production of PDGF-A by adult Leydig cells in vitro (Gnessi et al. 1992, Gnessi et al. 1995; Loveland et al. 1995). Concerning PDGF-R
, in prepubertal animals the immunostaining was localized in the interstitial cells of both +/+ and –/– testis, although in the latter the interstitial cells were less in number (Fig. 5C and Fig. D). In older animals, the WT testis continued to show PDGF-R
–positive cells between the tubules (Fig. 5 E), while the null testis showed a steadily decreasing number of positive cells, culminating in their complete absence at P42 (Fig. 5 F). The comparison between the testicular defects found in –/– mice and the normal expression pattern of PDGF-A and its receptor, indicates that paracrine PDGF-A/PDGF-R
signaling constitutes a critical part of the epithelial-mesenchymal interaction, essential for adult Leydig cells development. PDGF-A does not influence the fetal generation of Leydig cells, as suggested by both the normal adrogenization and RLF-positive interstitial immunohistochemical staining of prepubertal –/– animals. Due to the lack of specific markers, we could not produce direct evidence that among the interstitial PDGF-R
–positive cells are indeed the precursors of the adult Leydig cells, but the spatiotemporal distribution of PDGF-R
-interstitial cells in normal mice seems to suggest this possibility. It is also reasonable to predict that a cell type specifically lost in PDGF-A–/– mice should carry the receptor for PDGF-A, and should locate close to the source of the ligand, as is the case for the PDGF-R
–positive interstitial mesenchymal cells described. However, given the chemotactic activity of PDGF-A (Heldin and Westermark 1999), we cannot exclude that, similarly to what is described for other PDGF-dependent developmental processes (Boström et al. 1996; Lindahl et al. 1997a,Lindahl et al. 1997b; Calver et al. 1998), PDGF-A might influence the long-range migration of Leydig stem cells, thus preventing their arrival in the gonads from primordial germ layer source besides proliferation and differentiation.
|
|
The plasma levels of luteinizing hormone (LH) were also measured. They were similar in –/– (1.6 ± 0.4 ng/ml; n = 4) and +/+ (1.4 ± 0.5 ng/ml; n = 6) animals between P10 and P25. In agreement with the testosterone reduction, in a null P42 animal the levels of LH (7.5 ng/ml) were higher than in control littermates (3.8 ± 0.3 ng/ml; n = 4). These data indicate that in PDGF-A null animals, the fate of the Leydig cells cannot be ascribed to an LH deficiency.
In conclusion, understanding of Leydig cell development is still incomplete. Although LH, androgens and IGF-1 are recognized important elements required for the completion of Leydig cell maturation, they cannot be the factors that regulate the commitment of stem cells to adult Leydig cell lineage (Benton et al. 1995). In fact, initial proliferation of stem cells can occur when LH is absent (Teerds et al. 1989), and animals with androgen insensitivity (Murphy et al. 1994) or IGF-1 gene deletion (Baker et al. 1996) develop Leydig cells, suggesting that a separate factor regulates the earliest stage of adult Leydig cell evolution. Our findings indicate that PDGF-A may be this factor, and suggest that adult Leydig cells arise from PDGF-R
progenitors.
The pivotal role played by PDGF-A in adult Leydig cells development suggests that PDGF-A may be a potential target for the master genes involved in testicular organogenesis. In this respect, it is worth mentioning that WT1, whose spatio-temporal Sertoli cells expression profile (Pelletier et al. 1991; Mundlos et al. 1993; Rackley et al. 1993; Del Rio-Tsonis et al. 1996) is virtually superimposable on that of PDGF-A, can either repress or activate the PDGF-A gene (Wang et al. 1992, Wang et al. 1993a, Wang et al. 1993b; Gashler et al., 1992), and has been involved in posttranscriptional processing within the Sertoli cells (Larsson et al. 1995). The dramatic testicular phenotype of the PDGF-A–/– animals is also of interest because recent studies have reported detection of PDGF-A and PDGF-R
in the human testis (Basciani, S., L. Gnessi, M. Arizzi, N. Rucci, S. Mariani, S. Ulisse, E.A. Jannini, G. Spera. 1999. Proceedings of the 81st Annual Meeting of the Endocrine Society, San Diego, CA. Abst. P2–P81). These considerations, coupled with our findings, may furnish a new approach for the understanding of the WT1-mediated mechanisms involved in testicular development and perhaps of WT1-dependent urogenital abnormalities and tumorigenesis (Hastie 1994; Reddy and Licht 1996; Menke et al. 1998). Moreover, a local impairment of the PDGF-A/ PDGF-R
system may provide a new conceptual framework for the comprehension of some forms of Leydig cells hypoplasia, with high LH, low testosterone, and no mutations of the LH receptor gene (Zenteno et al. 1999), and of cases of spermatogenetic failure, which are probably due to intratesticular testosterone deficiency in man (Sharpe 1994).
| Acknowledgments |
|---|
The study was supported by grants from the Italian MURST progetti di ricerca di Ateneo (ex quota 60%), the Swedish Cancer Foundation, the Swedish Medical Research Council, the Göran Gustafsson Foundation, the Inga-Britt and Arne Lundberg Foundation, and National Institutes of Health grants CA-74907 and NS-36366. S. Basciani and S. Mariani are recipient of a postdoctoral fellowship of the University of Rome "La Sapienza".
Abbreviations used in this paper: BrdU, bromodeoxyuridine; LH, luteinizing hormone; PAS, periodic acid-Schiff; PMC, peritubular myoid cells; RLF, relaxin-like factor; TUNEL, TdT-mediated dUTP biotin nick end labeling; WT, wild-type.
| References |
|---|
|
|
|---|
Baker J., Hardy M.P., Zhou J., Bondy C., Lupu F., Bellve A.R. & Efstratiadis A.. Effect of an IGF1 gene null mutation on mouse reproduction, Mol. Endocrinol., 10, 1996, 903–918.
Balvers M., Spiess A.-N., Domagalaski R., Hunt N., Kilic E., Mukhopadhyay A.K., Hanks E., Charlton H.M. & Ivell R.. Relaxin-like factor expression as a marker of differentiation in the mouse testis and ovary, Endocrinology., 139, 1998, 2960–2970.
Benton L., Shan L.-X. & Hardy M.P.. Differentiation of adult Leydig cells, J. Steroid Biochem. Mol. Biol., 53, 1995, 61–68.[Medline]
Betsholtz C. & Raines E.W.. Platelet-derived growth factora key regulator of connective tissue cells in embryogenesis and pathogenesis, Kidney Int., 51, 1997, 1361–1369.[Medline]
Boström H., Willetts K., Pekny M., Leveen P., Lindahl P., Hedstrand H., Pekna M., Hellstrom M., Gebre-Medhin S. & Schalling M.. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis, Cell., 85, 1996, 863–873.[Medline]
Calver A.R., Hall A.C., Yu W.P., Walsh F.S., Heath J.K., Betsholtz C. & Richardson W.D.. Oligodendrocyte population dynamics and the role of PDGF in vivo, Neuron., 20, 1998, 869–882.[Medline]
Del Rio-Tsonis K., Covarrubias L., Kent J., Hastie N.D. & Tsonis P.A.. Regulation of the Wilms' tumor gene during spermatogenesis, Dev. Dyn, 207, 1996, 372–381.[Medline]
Fruttiger M., Karlsson L., Hall A.C., Abramsson A., Calver A.R., Bostrom H., Willetts K., Bertold C.-H., Heath J.K., Betsholtz C. & Richardson W.D.. Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice, Development., 126, 1999, 457–467.[Abstract]
Gashler, A.L., D.T. Bonthron, S.L. Madden, F.J.J. Rauscher 3rd, T. Collins, and V.P. Sukhatme. 1992. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms' tumor suppressor WT1. Proc. Natl. Acad. Sci. USA. 89:10984–10988.
Ge R.-S., Shan L.-X. & Hardy M.P.. Pubertal development of Leydig cells, Payne A., Hardy M.P. & Russell L.D., The Leydig cell, 1996, 159–173, Cache River Press, Vienna, IL.
Gnessi L., Emidi A., Farini D., Scarpa S., Modesti A., Ciampani T., Silvestroni L. & Spera G.. Rat Leydig cells bind platelet-derived growth factor through specific receptors and produce platelet-derived growth factor-like molecules, Endocrinology., 130, 1992, 2219–2224.
Gnessi L., Emidi A., Jannini E.A., Carosa E., Maroder M., Arizzi M., Ulisse S. & Spera G.. Testicular development involves the spatiotemporal control of PDGFs and PDGF receptors gene expression and action, J. Cell Biol., 131, 1995, 1105–1121.
Goodfellow P.N. & Lovell-Badge R.. SRY and sex determination in mammals, Annu. Rev. Genet., 27, 1993, 71–92.[Medline]
Gustafson M.L. & Donahoe P.K.. Male sex determinationcurrent concepts of male sexual differentiation, Annu. Rev. Med., 45, 1994, 505–524.[Medline]
Hastie N.D.. The genetics of Wilms' tumor a case of disrupted development, Annu. Rev. Genet, 28, 1994, 523–558.[Medline]
Heldin C.-H. & Westermark B.. Mechanism of action and in vivo role of platelet-derived growth factor, Physiol. Rev, 79, 1999, 1283–1316.
Karlsson L., Bondjers C. & Betsholtz C.. Roles for PDGF-A and sonic hedgehog in development of mesenchymal components of the hair follicle, Development., 126, 1999, 2611–2621.[Abstract]
Larsson S.H., Charlieu J.P., Miyagawa K., Engelkamp D., Rassoulzadegan M., Ross A., Cuzin F., van Heyningen V. & Hastie H.D.. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing, Cell., 81, 1995, 391–401.[Medline]
Lindahl P., Johansson B., Levéen P. & Betsholtz C.. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice, Science., 277, 1997, 242–245a.
Lindahl P., Karlsson L., Hellstrom M., Gebre-Medhin S., Willetts K., Heath J.K. & Betsholtz C.. Alveogenesis failure in PDGF-A–deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development, Development., 124, 1997, 3943–3953b.[Abstract]
Loveland K.L., Zlati K., Stein-Oakley A., Risbridger G. & de Kretser D.M.. Platelet-derived growth factor ligand and receptor subunit mRNA in the Sertoli and Leydig cells of the rat testis, Mol. Cell. Endocrinol., 108, 1995, 155–159.[Medline]
McLaren A.. Gonad developmentassembling the mammalian testis, Curr. Biol, 8, 1998, R175–R177.[Medline]
Menke A.L., van der Eb A.J. & Jochemsen A.G.. The Wilms' tumor 1 geneoncogene or tumor suppressor gene?, Int. Rev. Cytol, 181, 1998, 151–212.[Medline]
Mundlos S., Pelletier J., Darveau A., Bachmann M., Winterpacht A. & Zabel B.. Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues, Development., 119, 1993, 1329–1341.[Abstract]
Murphy L., Jeffcoate I.A. & O'Shaughnessy P.J.. Abnormal Leydig cell development at puberty in the androgen-resistant Tfm mouse, Endocrinology., 135, 1994, 1372–1377.[Abstract]
Parker K.L., Shendl A. & Schimmer B.P.. Gene interactions in gonadal development, Annu. Rev. Physiol., 61, 1999, 417–433.[Medline]
Pelletier J., Schalling M., Buckler A.J., Rogers A., Haber D.A. & Housman D.. Expression of the Wilms' tumor gene WT1 in the murine urogenital system, Genes Dev, 5, 1991, 1345–1356.
Rackley R.R., Flenniken A.M., Kuriyan N.P., Kessler P.M., Stoler M.H. & Williams B.R.. Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis, Cell. Growth Differ., 4, 1993, 1023–1031.[Abstract]
Reddy J.C. & Licht J.D.. The WT1 Wilms' tumor suppressor genehow much do we really know?, Biochim. Biophys. Acta., 1287, 1996, 1–28.[Medline]
Reinertsen K.K., Bronson R.T., Stiles C.D. & Wang C.. Temporal and spatial specificity of PDGF
receptor promoter in transgenic mice, Gene Expr., 6, 1997, 301–314.[Medline]
Russell L.D., Ettlin R.A., Sinha-Hikim A.P. & Clegg E.D., Histological and Histopathological Evaluation of the Testis, 1990, Cache River Press, Clearwater, FLpp. 286 pp.
Sharpe R.M.. Regulation of spermatogenesis, Knobil E. & Neill J.D., The Physiology of Reproduction, 1994, 1363–1434, Raven Press, New York.
Teerds K.J., de Rooij D.G., Rommerts F.F.G., van den Hurk R. & Wensing C.J.G.. Stimulation of the proliferation and differentiation of Leydig cells precursors after the destruction of existing Leydig cells with ethane dimethyl sulphonate (EDS) can take place in the absence of LH, J. Androl., 10, 1989, 472–477.
Wang Z.Y., Madden S.L., Deuel T.F. & Rauscher F.J. III.. The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene, J. Biol. Chem, 267, 1992, 21999–22002.
Wang Z.Y., Qiu Q.-Q. & Deuel T.F.. The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains, J. Biol. Chem, 268, 1993, 9172–9175a.
Wang Y., Qiu Q.-Q., Enger K.T. & Deuel T.F.. A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1, Proc. Natl. Acad. Sci. USA., 90, 1993, 8896–8900b.
Yomogida K., Ohtani H., Harigae H., Ito E., Nishimune Y., Engel J.D. & Yamamoto M.. Developmental stage- and spermatogenic cycle-specific expression of transcription factor GATA-1 in mouse Sertoli cells, Development., 120, 1994, 1759–1766.[Abstract]
Zenteno J.C., Canto P., Kofman-Alfaro S. & Mendez J.P.. Evidence for genetic heterogeneity in male pseudohermaphroditism due to Leydig cell hypoplasia, J. Clin. Endocrinol. Metab, 84, 1999, 3803–3806.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|